5-amino-1mq preclinical studies — 50mg | NNMT Inhibitor (NAD+ Axis) 5-Amino-1MQ Vial — Lyophilized, HPLC

50mg Per Capsule

The AAFP recommends injectable therapy when rapid improvement is needed for severe deficiency or serious neurologic involvement

The National Health and Nutrition Examination Survey estimated that up to 20% of adults over 50 may have borderline B12 deficiency

Allergic Reactions: While uncommon, some individuals may experience allergic reactions to the injection, which can include itching, rash, or difficulty breathing

Due to change in size and shape, the movement of red blood cells from bone marrow to the bloodstream become ineffective, often leading to megaloblastic anemia

Samples are prepared by grinding, solvent extraction, and centrifugal purification before injection